ARTIVION, INC. Gain (Loss) on Disposition of Assets
ARTIVION, INC. (AORT) reported Gain (Loss) on Disposition of Assets of $7.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-18.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-02-18
- ARTIVION, INC. gain (loss) on disposition of assets for the quarter ending 2025-12-31 was $3.50M.
- ARTIVION, INC. gain (loss) on disposition of assets for the quarter ending 2025-09-30 was $3.50M.
- ARTIVION, INC. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $0.00.
- ARTIVION, INC. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was $0.00.
- ARTIVION, INC. gain (loss) on disposition of assets for fiscal 2025 was $7.00M.
- ARTIVION, INC. gain (loss) on disposition of assets for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ARTIVION, INC. gain (loss) on disposition of assets for fiscal 2023 was $14.25M.
- ARTIVION, INC. gain (loss) on disposition of assets for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $7.00M derived: sum of 2 quarters · filed 2026-02-18 | $7.00M 10-K · filed 2026-02-18 | |
| 2025-09-30 | $3.50M 10-Q · filed 2025-11-07 | $3.50M 10-Q · filed 2025-11-07 | ||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $0.00 derived: sum of 2 quarters · filed 2026-02-18 | $0.00 derived: sum of 3 quarters · filed 2026-02-18 | $0.00 10-K · filed 2026-02-18 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-09 | $0.00 10-Q · filed 2024-08-09 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-18 | $0.00 derived: sum of 2 quarters · filed 2026-02-18 | $14.25M derived: sum of 3 quarters · filed 2026-02-18 | $14.25M 10-K · filed 2026-02-18 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $14.25M derived: sum of 2 quarters · filed 2024-11-08 | $14.25M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $14.25M 10-Q · filed 2024-08-09 | $14.25M 10-Q · filed 2024-08-09 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $0.00 derived: sum of 2 quarters · filed 2025-02-28 | $0.00 derived: sum of 3 quarters · filed 2025-02-28 | $0.00 10-K · filed 2025-02-28 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||
| 2021-12-31 | $15.92M 10-K · filed 2024-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |